Nanotechnology uses the unique properties of objects that function as a unit within the
overall size range of 1–1,000 nanometres. The engineering of nanostructure materials …

Vaccination is the best way to prevent and reduce the damage caused by infectious
diseases in animals and humans. So, several vaccines are used for prophylactic purposes …

Influenza Vaccines for the Future | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

The recent FDA approval of sipuleucel-T (Provenge®), a patient-specific immunotherapy for
androgen-independent prostate cancer developed by Dendreon Corporation, has provided …

Balancing immunogenicity with inflammation is a central tenet of vaccine design, especially
for subunit vaccines that utilize traditional pro-inflammatory adjuvants. Here we report that by …

Vaccine adjuvants are applied to amplify the recipient's specific immune responses against
pathogen infection or malignancy. A new generation of adjuvants is being developed to …

Ever since the development of the first vaccine, vaccination has had the great impact on
global health, leading to the decrease in the burden of numerous infectious diseases …

Safe, effective adjuvants that enhance vaccine potency, including induction of neutralizing
Abs against a broad range of variant strains, is an important strategy for the development of …

An effective protein-based vaccine for tuberculosis will require a safe and effective adjuvant.
There are few adjuvants in approved human vaccines, including alum and the oil-in-water …

Influenza infections continue to cause significant annual morbidity and mortality despite
ongoing influenza vaccine research. Adjuvants are administered in conjunction with …